CareCloud to Present at The Microcap Conference 2025
CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
The company's management team will deliver a corporate presentation highlighting recent developments and strategic initiatives. They will also engage in one-on-one meetings with institutional and individual investors. Co-CEO Stephen Snyder emphasized several key milestones, including the planned resumption of Preferred Stock dividends in February 2025, shareholder approval for increasing authorized common shares, and strong profitability growth during 2024.
CareCloud (Nasdaq: CCLD), fornitore di soluzioni tecnologiche per la sanità e di intelligenza artificiale generativa, ha annunciato la sua partecipazione a The Microcap Conference 2025, in programma dal 28 al 30 gennaio 2025, presso il Borgata Hotel Spa & Casino di Atlantic City, NJ.
Il team di gestione dell'azienda presenterà un intervento aziendale in cui metterà in evidenza gli sviluppi recenti e le iniziative strategiche. Parteciparanno inoltre a incontri one-to-one con investitori istituzionali e individuali. Il Co-CEO Stephen Snyder ha sottolineato diversi traguardi chiave, tra cui la riattivazione dei dividendi sulle azioni privilegiate prevista per febbraio 2025, l'approvazione degli azionisti per l'aumento delle azioni comuni autorizzate e una forte crescita della redditività durante il 2024.
CareCloud (Nasdaq: CCLD), proveedor de tecnología sanitaria y soluciones de inteligencia artificial generativa, ha anunciado su participación en The Microcap Conference 2025, programada para el 28 al 30 de enero de 2025, en el Borgata Hotel Spa & Casino en Atlantic City, NJ.
El equipo directivo de la empresa realizará una presentación corporativa destacando los desarrollos recientes y las iniciativas estratégicas. También participarán en reuniones uno a uno con inversores institucionales e individuales. El Co-CEO Stephen Snyder enfatizó varios hitos clave, incluyendo la reanudación planificada de los dividendos de acciones preferentes en febrero de 2025, la aprobación de los accionistas para aumentar las acciones comunes autorizadas y un fuerte crecimiento de la rentabilidad durante 2024.
CareCloud (Nasdaq: CCLD), 의료 기술 및 생성적 AI 솔루션 제공업체,가 The Microcap Conference 2025에 참여한다고 발표했습니다. 이 회의는 2025년 1월 28일부터 30일까지 뉴저지 애틀랜틱 시티에 위치한 Borgata Hotel Spa & Casino에서 열립니다.
회사의 경영진은 최근 발전 사항과 전략적 이니셔티브를 강조하는 기업 발표를 진행할 것입니다. 또한 기관 및 개인 투자자와 일대일 회의에 참여할 예정입니다. 공동 CEO인 Stephen Snyder는 2025년 2월에 예정된 우선주 배당금의 재개, 승인된 보통주 증가에 대한 주주 승인, 2024년 동안의 강력한 수익성 성장 등 여러 주요 이정표를 강조했습니다.
CareCloud (Nasdaq: CCLD), fournisseur de technologies de santé et de solutions d'IA générative, a annoncé sa participation à The Microcap Conference 2025, prévue du 28 au 30 janvier 2025, au Borgata Hotel Spa & Casino à Atlantic City, NJ.
La direction de l'entreprise présentera une présentation d'entreprise mettant en avant les développements récents et les initiatives stratégiques. Ils participeront également à des réunions en tête-à-tête avec des investisseurs institutionnels et individuels. Le Co-CEO Stephen Snyder a souligné plusieurs jalons clés, y compris la reprise prévue des dividendes sur les actions privilégiées en février 2025, l'approbation des actionnaires pour l'augmentation des actions ordinaires autorisées, et une forte croissance de la rentabilité en 2024.
CareCloud (Nasdaq: CCLD), Anbieter von Gesundheitstechnologie und generativen KI-Lösungen, hat seine Teilnahme an The Microcap Conference 2025 angekündigt, die vom 28. bis 30. Januar 2025 im Borgata Hotel Spa & Casino in Atlantic City, NJ, stattfinden wird.
Das Management-Team des Unternehmens wird eine Unternehmenspräsentation halten, in der die aktuellen Entwicklungen und strategischen Initiativen hervorgehoben werden. Sie werden auch in Einzelgespräche mit institutionellen und privaten Investoren eintreten. Co-CEO Stephen Snyder betonte mehrere wichtige Meilensteine, einschließlich der geplanten Wiederaufnahme der Dividenden für Vorzugsaktien im Februar 2025, der Genehmigung durch die Aktionäre zur Erhöhung der autorisierten Stammaktien und eines starken Gewinnwachstums im Jahr 2024.
- None.
- None.
Somerset, NJ, Jan. 28, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (the “Company”) (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare technology and generative AI solutions for medical practices and health systems nationwide, is pleased to announce its participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025 at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
CareCloud’s management team will deliver a corporate presentation highlighting the Company’s recent developments, innovative solutions, and strategic growth initiatives. Additionally, the team will participate in one-on-one meetings with institutional and individual investors to explore opportunities and discuss CareCloud’s roadmap for continued growth and value creation.
“We are excited to discuss CareCloud’s many recent milestones, including the imminent resumption of our Preferred Stock dividends in February 2025, the overwhelming support we received from shareholders in our most recent proxy to increase our authorized common shares, and our strong profitability growth during 2024,” said Stephen Snyder, Co-CEO of CareCloud. “These achievements, together with our stock performance over the last year, reflect investor confidence in our strategy and execution.”
About The Microcap Conference 2025
The Microcap Conference is the largest independent microcap event in the U.S., bringing together top-tier investors and executives from growth-oriented companies. The event provides an unparalleled platform for companies to showcase their value propositions through corporate presentations, expert panels, and networking opportunities.
The 2025 conference highlights include:
- Keynote Speakers: Renowned industry leaders, including Jon Ledecky, Co-Owner of the New York Islanders, and Tom Gardner, CEO of Motley Fool, will share their insights on investing and market trends.
- Expert Panels and Presentations: Financial commentators Ron Insana (CNBC) and Charlie Gasparino (FOX Business) will cover pressing topics, including capital formation, regulatory updates, and equity market trends.
- Entertainment Headliner: Comedian and Netflix star Tom Papa will headline an evening performance, adding a touch of entertainment to the event.
Hosted by DealFlow Events, The Microcap Conference is celebrated for combining high-quality financial insights with engaging networking and entertainment experiences. For more information, visit The Microcap Conference.
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at www.carecloud.com.
To listen to video presentations by CareCloud’s management team, read recent press releases and view our latest investor presentation, please visit ir.carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
When is CareCloud (CCLD) presenting at The Microcap Conference 2025?
When will CareCloud (CCLD) resume Preferred Stock dividend payments?
What recent milestones did CareCloud (CCLD) achieve in 2024?